Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 3;7(3):104.
doi: 10.3390/pharmacy7030104.

Tetracycline Allergy

Affiliations
Review

Tetracycline Allergy

Leslie A Hamilton et al. Pharmacy (Basel). .

Abstract

Despite the widespread use of tetracycline antibiotics since the late 1940s, tetracycline hypersensitivity reactions have rarely been described in the literature. A comprehensive PubMed search was performed, including allergic and serious adverse reactions attributed to the tetracyclines class of antibiotics. Of the evaluated tetracycline analogs, minocycline was attributed to the greatest overall number and severity of serious adverse events reported in the literature, with notable reactions primarily reported as respiratory and dermatologic in nature. Reactions to tetracycline have also been well described in the literature, and although dermatologic reactions are typically less severe in comparison with minocycline and doxycycline, various reports of anaphylactic reactions exist. Although doxycycline has been noted to have had the fewest reports of severe allergic reactions, rare descriptions of life-threatening reactions are still reported in the literature. Allergic reactions regarding tetracyclines are rare; however, adverse reaction type, severity, and frequency among different tetracycline analogs is somewhat variable. A consideration of hypersensitivity and adverse reaction incidence should be performed prior to the selection of individual tetracycline entities.

Keywords: allergic reaction; allergy; doxycycline; minocycline; tetracycline.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Nelson M.L., Levy S.B. The history of the tetracyclines. Ann. N. Y. Acad. Sci. 2011;1241:17–32. doi: 10.1111/j.1749-6632.2011.06354.x. - DOI - PubMed
    1. Verbalis J.G., Goldsmith S.R., Greenberg A., Korzelius C., Schrier R.W., Sterns R.H., Thompson C.J. Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations. Am. J. Med. 2013;126:S1–S42. doi: 10.1016/j.amjmed.2013.07.006. - DOI - PubMed
    1. Mandell L.A., Wunderink R.G., Anzueto A., Bartlett J.G., Campbell G.D., Dean N.C., Dowell S.F., File T.M., Musher D.M., Niederman M.S., et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007;44:S27–S72. doi: 10.1086/511159. - DOI - PMC - PubMed
    1. Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., Kaplan S.L., Karchmer A.W., Levine D.P., Murray B.E., et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin- resistant staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 2011;52:e18–e55. doi: 10.1093/cid/ciq146. - DOI - PubMed
    1. Stevens D.L., Bisno A.L., Chambers H.F., Dellinger E.P., Goldstein E.J., Gorbach S.L., Hirschmann J.V., Kaplan S.L., Montoya J.G., Wade J.C. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin. Infect. Dis. 2014;59:e10–e52. doi: 10.1093/cid/ciu296. - DOI - PubMed

LinkOut - more resources